Co-diagnostics, inc. to participate at fime 2024 in miami beach, june 19-21

Salt lake city , june 18, 2024 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the company has been invited to participate in the utah booth at the fime trade show in miami beach, florida, on june 19-21. fime is described as the americas' leading medical trade expo for medical device and product purchasers, for establishing new supplier relationships, and for strengthening business ties with the global medical device and equipment market, with exhibitors from 116 countries and more than 15,000 expected professional attendees.
CODX Ratings Summary
CODX Quant Ranking